What is NDC 67457-854?

67457-854 is the product NDC for adenosine, Adenosine 3 mg/mL injection, listed with the FDA by Mylan Institutional LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Mylan Institutional LLC, NDC labeler code 67457. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for adenosine?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

adenosine NDC 67457-854 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67457-854Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67457-0854Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67457-854-04	6745708540467457085404	10 VIAL, SINGLE-DOSE in 1 CARTON (67457-854-04) / 4 mL in 1 VIAL, SINGLE-DOSE (67457-854-00)Marketed from May 8, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): adenosine
Generic name (nonproprietary): adenosine
Active ingredients: Adenosine — 3 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Mylan Institutional LLCNDC labeler code 67457
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078686
Marketing start: May 8, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Adenosine Receptor Agonists (Mechanism)
Identifiers: Product ID 67457-854_a807e222-e981-48ee-8d2c-b226b90347bbSPL ID a807e222-e981-48ee-8d2c-b226b90347bbSPL set ID d2d06ee6-c89f-49f7-9e2c-46d33ce877a9RxCUI 1654169, 1654186UNII K72T3FS567UPC 0367457855028
Pharmacologic class: Adenosine Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N467457085404 followed by a unit qualifier and the quantity

Package 67457-0854-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 16, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Intravenous adenosine injection is indicated for the following: Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine administration. It is important to be sure the adenosine injection solution actually reaches the systemic circulation (see Dosage and Administration ). Adenosine injection does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. In the presence of atrial flutter or atrial fibri…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67457-854

What is NDC 67457-854?: 67457-854 is the product NDC for adenosine, Adenosine 3 mg/mL injection, listed with the FDA by Mylan Institutional LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: adenosine.
What is the active ingredient?: Adenosine.
Who is the labeler?: Mylan Institutional LLC, NDC labeler code 67457. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for adenosine?: 28 other product NDCs are listed under this name. See all adenosine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other adenosine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-207	71288-0207-21
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-208	71288-0208-30
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	REMEDYREPACK INC.	70518-4207	70518-4207-0070518-4207-02
Adenosineadenosine injection, solution	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9993	00404-9993-02
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1632	51662-1632-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1631	51662-1631-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Sagent Pharmaceuticals	25021-318	25021-0318-0225021-0318-04
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7335	71872-7335-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	ProPharma Distribution	84549-318	84549-0318-02
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	NorthStar Rx LLC	16714-556	16714-0556-01

All 29 adenosine NDCs

Other NDCs under ANDA 078686

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078686
Product	Strength	Form · route	Labeler	Product NDC
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1631
adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Mylan Institutional LLC	67457-855
adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7209
adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Mylan Institutional LLC	72078-033